Ellen Rohde
Impact in
- Bioengineering top 10%
Papers in
-
- CRISPR and Genetic Engineering 4
- RNA regulation and disease 2
-
- Nanoplatforms for cancer theranostics 3
- Microfluidic and Capillary Electrophoresis Applications 2
- Co-authors
- Andrew M. Bellinger (5 shared papers)Sekar Kathiresan (6 shared papers)Amit V. Khera (5 shared papers)Anne Marie Mazzola (4 shared papers)Richard Lee (3 shared papers)Scott B. Vafai (2 shared papers)Maurine Braun (2 shared papers)Colin Platt (2 shared papers)
- Journals
- Bioorganic & Medicinal Chemistry Letters (2 papers)Electrophoresis (1 paper)Molecular Cancer Therapeutics (1 paper)ACS Medicinal Chemistry Letters (1 paper)Analytical Chemistry (1 paper)
- Partner nations
- United StatesGermanyCanada
In The Last Decade
Ellen Rohde
21 papers receiving 531 citations
Hit Papers
Peers
Comparison fields: 5 of 81
- Business and International Management 12
- Bioengineering 30
- Molecular Biology 257
- Electrochemistry 18
- Biomaterials 37
Countries citing papers authored by Ellen Rohde
This map shows the geographic impact of Ellen Rohde's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ellen Rohde with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ellen Rohde more than expected).
Fields of papers citing papers by Ellen Rohde
This network shows the impact of papers produced by Ellen Rohde. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ellen Rohde. The network helps show where Ellen Rohde may publish in the future.
Co-authors
The 25 scholars most cited alongside Ellen Rohde, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 21 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Efficacy and Safety of an Investigational Single-Course CRISPR Base-Editing Therapy Targeting PCSK9 in Nonhuman Primate and Mouse Models Hit paper breakdown → | 2022 | 132 |
| 2 | GalNAc-Lipid nanoparticles enable non-LDLR dependent hepatic delivery of a CRISPR base editing therapy Hit paper breakdown → | 2023 | 93 |
| 3 | 2016 | 55 | |
| 4 | 2018 | 50 | |
| 5 | 1998 | 38 | |
| 6 | 1993 | 35 | |
| 7 | 2012 | 25 | |
| 8 | 1998 | 18 | |
| 9 | 2011 | 17 | |
| 10 | 2011 | 15 | |
| 11 | 2012 | 12 | |
| 12 | 2015 | 11 | |
| 13 | 2010 | 9 | |
| 14 | 2023 | 9 | |
| 15 | 2023 | 8 | |
| 16 | 2003 | 7 | |
| 17 | 2019 | 7 | |
| 18 | 2024 | 4 | |
| 19 | 2015 | 2 | |
| 20 | 2025 | 2 |
About Ellen Rohde
Ellen Rohde is a scholar working on Molecular Biology, Biomedical Engineering, Oncology, Immunology and Cellular and Molecular Neuroscience, having authored 21 papers that have together received 550 indexed citations. Recurring topics across this work include CRISPR and Genetic Engineering (4 papers), Drug Transport and Resistance Mechanisms (4 papers), Nanoplatforms for cancer theranostics (3 papers), Alzheimer's disease research and treatments (2 papers), Computational Drug Discovery Methods (2 papers), Biosimilars and Bioanalytical Methods (2 papers), Microfluidic and Capillary Electrophoresis Applications (2 papers) and RNA regulation and disease (2 papers). The work is most often cited by research in Business and International Management (12 citations), Bioengineering (30 citations), Molecular Biology (257 citations), Electrochemistry (18 citations) and Biomaterials (37 citations). Ellen Rohde has collaborated with scholars based in United States, Germany and Canada. Frequent co-authors include Andrew M. Bellinger, Sekar Kathiresan, Amit V. Khera, Anne Marie Mazzola, Richard Lee, Scott B. Vafai, Maurine Braun, Colin Platt, Stephen Naylor and Andy J. Tomlinson. Their work appears in journals such as Bioorganic & Medicinal Chemistry Letters, Electrophoresis, Molecular Cancer Therapeutics, ACS Medicinal Chemistry Letters and Analytical Chemistry.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.